Pfizer (PFE) EPS (Basic) Growth (3y) (2012 - 2026)
Powered by 
Analysis
Pfizer (PFE) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 5.11% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 21.23% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 38.72% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 14.72% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -28.08% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -36.03% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 47.44% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 12.25% |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn | 22.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -28.08% |
| Mar 29, 2026 | -21.68% |
| Jun 29, 2025 | -33.76% |
| Mar 30, 2025 | -27.95% |
| Sep 29, 2024 | -25.99% |
| Jun 30, 2024 | -79.60% |
| Mar 31, 2024 | -14.23% |
| Jul 2, 2023 | -13.04% |
| Apr 2, 2023 | 17.58% |
| Jul 3, 2022 | 24.92% |
| Apr 3, 2022 | 26.61% |
| Oct 3, 2021 | 67.92% |
| Jul 4, 2021 | 14.73% |
| Apr 4, 2021 | 13.44% |
| Sep 27, 2020 | 46.19% |
| Jun 28, 2020 | 6.82% |
| Mar 29, 2020 | 5.20% |
| Dec 31, 2019 | -40.99% |
| Sep 29, 2019 | 83.75% |
| Jun 30, 2019 | 38.77% |